10th 3D Tissue Models Summit 2025
38 38 people viewed this event.
Following the FDA’s introduction of the Modernization Act 3.0 and the latest guidance on new approach methods (NAMs), GSK developing a new lung organoid model to empower pulmonary fibrosis research, and Merck acquiring HUB Organoids to enable more effective drug development and reduce reliance on animal testing, it’s an exciting time for pharma and biotech to leverage complex in vitro models in drug discovery and development.
Date and Time: Tuesday, 06 May 2025 at 09:00 to Thursday, 08 May 2025 at 15:15
Venue details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
Organizer: Hanson Wade
Contact Person: Lucy Rutherfood
Email: info@hansonwade.com